Save The Date: Tumor Heterogeneity, Plasticity and Therapy (4th edition)
The fourth edition of the VIB conference “Tumor heterogeneity, plasticity and therapy” is coming up.
Growing evidence highlights the bidirectional interactions between tumor cells and their microenvironment as key drivers of tumor evolution and therapy resistance.
Within a tumor, cancer cells exhibit significant variability, posing a major challenge for therapy, as treatments often target only a subset of tumor cells. Furthermore, cancer cell plasticity enables rapid adaptation to therapeutics and the development of tolerance and resistance, presenting additional challenges for both targeted and immunotherapies.
More information about the conference will be available soon on the official website.
Our members & strategic partners
Organizations with expertise in immunology, oncology, vaccinology and infectious diseases, are invited to join Immunity for Health. Together, we build a strong network, fostering innovation in diagnostics, medical devices, immunotherapeutics, and vaccines for humans and animals and across the entire value chain—from R&D to manufacturing, supply, marketing, and beyond. Join us to make impact!
